Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Anavex Life Sciences Corp. - Common Stock (NQ:AVXL)

3.825 +0.185 (+5.08%)
Streaming Delayed Price Updated: 10:53 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Anavex Life Sciences Corp. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Why Clinical Stage Biopharmaceutical Company Anavex Shares Are Tanking Today ↗
Anavex Life Sciences Corp. (NASDAQ: AVXL) shares are trading lower in the premarket session on Tuesday after the company provided an  
Via Benzinga
News headline image
Anavex Life Sciences Stock Sees RS Rating Jump To 86; Is It One To Watch? ↗
A Relative Strength Rating upgrade for Anavex Life Sciences shows improving technical performance. 
Via Investor's Business Daily
News headline image
Crude Oil Falls; RedHill Biopharma Shares Spike Higher ↗
U.S. stocks traded mixed toward the end of trading on Monday. The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69. The S&P 500 also fell, dropping, 0.08% to 4,555.47. 
Via Benzinga
Topics Stocks
News headline image
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. 
Via Benzinga
News headline image
Recap: Anavex Life Sciences Q4 Earnings ↗
 
Via Benzinga
News headline image
Anavex Stock Is Moving Higher Monday: What's Going On? ↗
Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Monday. 
Via Benzinga
News headline image
Preview: Anavex Life Sciences's Earnings ↗
 
Via Benzinga
News headline image
Wall Street Slumps As "Fear Gauge" Mounts Comeback ↗
Wall Street is placing its four-week rally on hold, as investors watch the retail sector following an online record-setting Black Friday and await this week's slew of economic data. 
Via Talk Markets
News headline image
Nasdaq Moves Higher; US New Home Sales Fall In October ↗
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday. The Dow traded down 0.23% to 35,310.40 while the NASDAQ rose 0.21% to 14,280.12. The S&P 500 also... 
Via Benzinga
Topics Stocks
News headline image
General Dynamics, Microsoft, Waste Management And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
News headline image
The Latest Analyst Ratings for Anavex Life Sciences ↗
 
Via Benzinga
News headline image
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates... 
Via Benzinga
News headline image
Anavex Life Sciences Releases Encouraging Long Term Data From Rett Syndrome Study ↗
Anavex Life Sciences Corp (NASDAQ: AVXL) announced that long-term clinical study results from the U.S. 
Via Benzinga
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Analyst Ratings for Anavex Life Sciences ↗
 
Via Benzinga
News headline image
This Short-Squeeze Candidate Could Actually Pan Out in the Long Run ↗
Short-sellers have piled into this clinical-stage biopharma stock. 
Via The Motley Fool
News headline image
Earnings Preview: Anavex Life Sciences ↗
 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today ↗
 
Via Benzinga
News headline image
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗
Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss. 
Via Benzinga
Here's How Much $100 Invested In Anavex Life Sciences 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
What's Going On With Anavex Life Sciences Shares Today? ↗
Anavex Life Sciences Corp (NASDAQ: AVXL) shares are trading higher Thursday after the company reported results from its Phase 2 study in patients with Parkinson's disease dementia showing beneficial... 
Via Benzinga
News headline image
Wall Street Thinks This Small-Cap Stock Can Quadruple in Value ↗
The company generates no revenue, but it may be worth taking a chance on as it possesses lots of upside. 
Via The Motley Fool
News headline image
Why Shares of Anavex Life Sciences Rose 12.4% in February ↗
The company's first-quarter earnings report detailed positive news regarding its pipeline. 
Via The Motley Fool
News headline image
Is Anavex Life Sciences Stock a Buy Now? ↗
A short squeeze could be a possibility if the company can prove that bearish investors are wrong about its business. 
Via The Motley Fool
News headline image
Why Anavex Life Sciences Stock Bolted Higher in January ↗
The biotech's shares have been steadily leaking higher following positive late-stage Alzheimer's disease trial results. 
Via The Motley Fool
News headline image
Anavex Life Sciences Stock Shows Improved Price Strength Rating ↗
Anavex Life Sciences stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 68 to 75. 
Via Investor's Business Daily
News headline image
3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗
All three stocks have promising therapies that could drive revenue in the coming years. 
Via The Motley Fool
News headline image
Top Picks For 2023: Anavex Life Sciences ↗
Anavex is a biopharmaceutical company dedicated to the development of novel drug candidates to treat central nervous system diseases, with encouraging results in Alzheimer’s, Parkinson’s, and Rett... 
Via Talk Markets
News headline image
Tesla To $205? Here Are 10 Other Price Target Changes For Tuesday ↗
Goldman Sachs cut Tesla, Inc. (NASDAQ: TSLA) price target from $235 to $205. Goldman Sachs analyst Mark Delaney maintained a Buy rating on the stock. Tesla shares fell 2.6% to $119.93 in pre-market... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.